Evaluation of Femaxeen® for control of urinary incontinence in women: A randomized, double-blind, placebo-controlled study.
- 2020-03
- RCT · n = 81
- Maturitas 133
- Santiago Palacios
- Marieta Ramirez
- Mariella Lilue
- Barbara Vega
- PubMed: 32005419
- DOI: 10.1016/j.maturitas.2019.12.008
- High evidence
- Clinical
Femaxeen significantly reduced ICIQ-SF and MHU scores from baseline to Day 60 and Day 90 in all UI types (p < 0.05 for all comparisons except ICIQ-SF scores for stress UI)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- once daily